Abstract:Interest is increasing in the use of different liquid chromatography techniques coupled online to mass spectrometry for the quantification of platinum anticancer drugs in human plasma to inform cancer chemotherapy. We developed, validated and studied the application of a method for quantification of intact oxaliplatin in human plasma using ultra high performance liquid chromatography hyphenated to inductively coupled plasma mass spectrometry (UHPLC-ICP-MS). Plasma samples were processed instantly after collection from patients to preserve oxaliplatin speciation by methanol-deproteinization, and storage of diluted supernatants (plasma:methanol 1:2 v/v) at -80 °C. UHPLC separation of intact oxaliplatin and internal standard (carboplatin) was achieved using a C18 column and linear gradient mobile phase (Mobile phase A: water-methanol (97:3 v/v), 0.075 mM sodium dodecyl sulfate, 9.79 nM thallium adjusted to pH 2.5 with trifluoromethanesulfonic acid; Mobile phase B: 100 % methanol (v/v)) with ICP-MS detection to monitor platinum and thallium at m/z 195 and 205, respectively. The limit of quantification was 50 nM in methanol-deproteinized diluted plasma (1:2 v/v). Linearity was established for calibration standards ranging from 50 to 500 nM made in methanol-deproteinized diluted plasma (1:2 v/v), and for dilution of higher concentration samples in blank matrix containing internal standard (final dilution 1:29 v/v). Intra-day and inter-day accuracy ranged from 96.8 to 103 % of nominal concentration and precision from 0.62 to 2.49 % coefficient of variation. Recovery was complete and a matrix effect confirmed the requirement for matrix-matched standards. Intact oxaliplatin was stable during storage for at least 473 days, and during analysis, in methanol-deproteinized diluted plasma (1:2 v/v). The method was applied to determining the plasma concentrations of intact oxaliplatin in patients undergoing cancer chemotherapy, and studies of oxaliplatin degradation in vitro. This improved method based on UHPLC-ICP-MS will allow more specific, efficient and reliable quantification of intact oxaliplatin in human plasma.

Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry

Preconcentration and determination of ultra-traces of platinum in human serum using the combined electrodeposition-electrothermal atomic absorption spectroscopy (ED-ETAAS) and chemometric method

Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues

Determination of Pt in biological samples by inductively coupled plasma atomic emission spectrometry (ICP-AES) with electrothermal vaporization (ETV)

DETERMINATION OF PLATINUM IN CLINICAL SAMPLES

Determination of Platinum, Palladium and Rhodium in Biological and Environmental Samples by Low Temperature Electrothermal Vaporization Inductively Coupled Plasma Atomic Emission Spectrometry with Diethyldithiocarbamate As Chemical Modifier

Speciation of platinum in blood plasma and urine by micelle-mediated extraction and graphite furnace atomic absorption spectrometry

Determination of Platinum in Serum Samples by Inductively Coupled Plasma Mass Spectrometry with Microscale Flow Injection Based on a Heated Spray Chamber

Determination Of Platinum In Serum And Tissues By Inductively Coupled Plasma-Atomic Emission Spectrometry

Determination of Platinum in Human Plasma by Microchip-based Nanoflow Injection and Inductively Coupled Plasma Mass Spectrometry

Platinum determination by inductively coupled plasma-sector field mass spectrometry (ICP-SFMS) in different matrices relevant to human biomonitoring

Analysis of free cisplatin in microdialysates and plasma ultrafiltrate by liquid chromatography-tandem mass spectrometry

Solid Phase Extraction and Spectrophotometric Determination of Platinum(Iv) with N-(3,5-Dihydroxyphenyl)-N '-(4-aminobenzenesulfonate)- Thiourea

Determination of unbound platinum concentrations in human plasma using ultrafiltration and precipitation methods

Improved method for quantification of intact oxaliplatin by ultra high performance liquid chromatography-inductively coupled plasma mass spectrometry: Applications to clinical and speciation studies

Study of Solid Phase Extraction Prior to Spectrophotometric Determination of Platinum with N-(3,5-Dimethylphenyl)-N′-(4-Aminobenzenesulfonate)-Thiourea

Determination of carboplatin in plasma by graphite furnace atomic absorption spectrophotometry

Electrothermal Vaporization Inductively Coupled Plasma Atomic Emission Spectrometry Determination of Gold, Palladium, and Platinum Using Chelating Resin YPA4 As Both Extractant and Chemical Modifier

Platinum(II)-Oligonucleotide Coordination Based Aptasensor for Simple and Selective Detection of Platinum Compounds

Use of platinum as a modifier in the sensitive detection of tellurium in biological samples